Specific Safety Issues With Mimvey

Specific Mimvey Warnings and Precautions

Some warnings and precautions to be aware of prior to using Mimvey include the following:
 
 
  • Let your healthcare provider know if you have abnormal vaginal bleeding (such as heavy bleeding or bleeding between periods) while taking Mimvey, as this may be a sign of precancerous or cancerous changes in the uterus. Your healthcare provider can perform the necessary tests to rule out cancer.
     
  • When possible, this medication should be stopped four to six weeks before many surgeries in order to help prevent blood clots.
     
  • Estrogen-containing drugs seem to increase the risk of dementia. In no case should Mimvey be used to prevent or treat dementia, as it is not effective for this use.
     
  • Mimvey should be used with caution in women who have low calcium levels in the blood (known medically as hypocalcemia).
     
  • Women who take estrogen-containing medications like Mimvey have an increased risk for gallbladder disease.
     
  • Let your healthcare provider know right away if you notice any vision changes. This can signal a blood clot in the retina, a possible side effect of Mimvey.
     
  • This medication can cause high blood pressure (hypertension) or high triglycerides in some women. Your healthcare provider should monitor you for these problems.
     
  • If you have had jaundice (yellowing of the whites of the eyes or skin) due to estrogens or pregnancy in the past, Mimvey could cause similar problems to recur. If this happens, your healthcare provider will probably advise you to stop taking the drug.
     
  • If you have an underactive thyroid (hypothyroidism), Mimvey may increase your body's requirement for thyroid hormones. Your healthcare provider should monitor you and adjust the dose of your thyroid medications as necessary.
     
  • Mimvey may make epilepsy, porphyria, asthma, diabetes, migraine headaches, lupus, and hepatic hemangiomas worse.
     
  • This drug can cause fluid retention, which can cause problems for people with congestive heart failure (CHF) or kidney problems.
     
  • It is not clear whether Mimvey increases the risk of ovarian cancer. Some studies have shown an increased risk, while others have not.
     
  • This medication can make endometriosis symptoms worse.
     
  • Mimvey can interact with a number of different medications (see Drug Interactions With Mimvey)
     
  • This drug should not be used during pregnancy (see Activella and Pregnancy; Mimvey is a generic version of Activella®).
     
  • The hormones in Mimvey pass through breast milk. Therefore, if you are breastfeeding or plan to start, discuss this with your healthcare provider prior to taking the drug (see Activella and Breastfeeding).
     
Men and Osteoporosis

Mimvey Drug Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.